U.S. Software Stock News

NasdaqCM:NEO
NasdaqCM:NEOHealthcare

Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness

NeoGenomics (NEO) has drawn attention after its share price closed at $8.24, with recent returns showing pressure over the past month and past 3 months, prompting investors to reassess the cancer testing specialist. See our latest analysis for NeoGenomics. The recent 1 day share price return of 4.57% comes after a 30 day share price decline of 27.59% and a 1 year total shareholder return of 16.26% in the red. This indicates that pressure has been building for some time rather than momentum...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

How Veracyte’s New AI-Focused CTO Role At Veracyte (VCYT) Has Changed Its Investment Story

Veracyte, Inc. recently appointed Kevin Haas, Ph.D., as its first Chief Development and Technology Officer, tasking him with overseeing end-to-end product development across diagnostic assays, software, bioinformatics and program management to support its expanding global portfolio of laboratory-developed tests and in vitro diagnostic products. This new role, filled by a leader with deep experience in automated lab technology, AI and genomics platforms, underscores Veracyte’s intent to more...
NYSE:FIHL
NYSE:FIHLInsurance

A Look At Fidelis Insurance Holdings (FIHL) Valuation After Its Large Share Buyback Program Completion

What Fidelis Insurance Holdings’ completed buyback means for shareholders Fidelis Insurance Holdings (FIHL) has just wrapped up a sizeable buyback, repurchasing 18,823,327 shares for US$351.4 million, equal to 18.24% of its share base under a program launched in August 2025. From October 1, 2025 to March 3, 2026 alone, the company bought back 16,988,264 shares, or 16.49% of its stock, at a time when the shares most recently closed at US$18.95. See our latest analysis for Fidelis Insurance...
NasdaqGS:PHVS
NasdaqGS:PHVSPharmaceuticals

Is New HAE Patient-Reported Outcome Study Altering The Investment Case For Pharvaris’ Deucrictibant (PHVS)?

Pharvaris recently reported that a company-sponsored real-world, mixed methods study on patient experiences during acute hereditary angioedema (HAE) attacks and related clinical endpoints has been published in Clinical Reviews in Allergy & Immunology, supporting the use of several patient-reported outcome (PRO) tools in ongoing and future deucrictibant trials. The study’s finding that patients view even small early improvements, captured by the End of Progression™ endpoint, as meaningfully...
NasdaqGS:EXTR
NasdaqGS:EXTRCommunications

A Look At Extreme Networks (EXTR) Valuation After Cellhub Healthcare Networking Collaboration

Extreme Networks (EXTR) shares are in focus after Cellhub, a healthcare technology aggregator and Primary Agent for T-Mobile, agreed to use the company’s AI-powered networking in its Hospitals Without Walls connectivity program. See our latest analysis for Extreme Networks. The recent Cellhub agreement comes as Extreme Networks trades at US$14.83, with a 7 day share price return of 5.70%, a 90 day share price return of 11.67%, and a 3 year total shareholder return of 17.70%. If you are...
NasdaqGS:SLAB
NasdaqGS:SLABSemiconductor

Did Silicon Labs’ In‑Tire Sensor Deal With BANF Just Shift Silicon Laboratories’ (SLAB) Investment Narrative?

Earlier this month, BANF announced a collaboration with Silicon Labs to integrate the ultra‑low‑power BG22 Bluetooth LE SoC and Secure Vault security into BANF’s new in‑tire, battery‑free sensor platform for autonomous and connected vehicles. By digitizing real‑time tire conditions with on‑tire data processing and wireless power transfer, the partnership turns tires into high‑value data sources for safety, fleet management, and future predictive services. We’ll now examine how embedding...
NasdaqGS:VSAT
NasdaqGS:VSATCommunications

How Viasat’s (VSAT) Earnings Beat Amid Softer Revenue and Insider Sale Has Changed Its Investment Story

In its latest quarter, Viasat reported earnings per share that exceeded analyst expectations even as revenue came in slightly below forecasts, reflecting resilient performance across its global satellite communications services. An interesting angle is that this earnings strength coincided with a pre-planned insider share sale by the Chief Accounting Officer, underscoring how routine trading plans can intersect with periods of strong operating results. We’ll now explore how Viasat’s...
NYSE:VOYA
NYSE:VOYADiversified Financial

A Look At Voya Financial’s Valuation After Earnings Miss And Post Results Share Price Drop

Voya Financial (VOYA) is back in focus after its latest quarterly update, where US$2.01b in revenue matched expectations but earnings per share fell short, and the stock has dropped 12.2% since the announcement. See our latest analysis for Voya Financial. Beyond the post results drop, Voya Financial’s share price has seen a 9.21% decline over 30 days and a 10.52% year to date share price return. Its 1 year total shareholder return of 2.98% and 5 year total shareholder return of 17.71% suggest...
NasdaqGS:ROP
NasdaqGS:ROPSoftware

A Look At Roper Technologies (ROP) Valuation As AI Expansion And Acquisitions Shape Investor Expectations

Roper Technologies (ROP) is back in focus after Q4 2025 results slightly beat EPS expectations but missed on revenue, while management doubled down on AI expansion, disciplined acquisitions, and conservative 2026 guidance. See our latest analysis for Roper Technologies. The mixed Q4 report and conservative 2026 outlook come after a volatile stretch. A 9.58% 1 month share price return contrasts with a 20.64% 3 month share price decline and a 38.41% 1 year total shareholder return loss,...
NasdaqGS:SVCO
NasdaqGS:SVCOSoftware

A Look At Silvaco Group (SVCO) Valuation After Earnings Beat And AI Segment Growth

Silvaco Group (SVCO) surprised the market with quarterly results that came in ahead of expectations, along with revenue guidance above earlier forecasts and cost cuts tracking better than management initially outlined. See our latest analysis for Silvaco Group. Silvaco Group’s recent earnings beat and upbeat guidance have been met with sharp share price momentum, with a 7 day share price return of 53.5% and a year to date share price return of 22%, even though the 1 year total shareholder...
NYSE:BALL
NYSE:BALLPackaging

Assessing Ball (BALL) Valuation After Q4 2025 Earnings Beat And Upgraded 2026 Outlook

Ball (BALL) caught investor attention after its Q4 2025 earnings topped Wall Street expectations, with shipment volumes up 6% and management outlining a positive 2026 EPS growth outlook that helped lift the share price. See our latest analysis for Ball. That earnings beat has been a clear turning point, with the share price up 20.0% over the past 90 days and a 1 year total shareholder return of 20.5%. However, the 5 year total shareholder return of 21.5% shows longer term performance has been...
NYSE:BLD
NYSE:BLDConsumer Durables

How Acquisition-Driven Revenue Surge and 2026 Outlook Could Impact TopBuild’s (BLD) Investors

TopBuild Corp. recently reported that fourth-quarter revenue rose 13.2%, driven largely by its acquisition program, including the SPI purchase completed last year. The company’s seven acquisitions in 2025 added nearly US$1.20 billion in sales and underpin its 2026 revenue outlook of US$5.93 billion to US$6.23 billion with adjusted EBITDA of US$1.01 billion to US$1.16 billion. We’ll now examine how this acquisition-fueled revenue growth and 2026 outlook could influence TopBuild’s existing...
NasdaqGM:NIU
NasdaqGM:NIUAuto

Niu Technologies (NasdaqGM:NIU) Q4 Loss After Q3 Profit Challenges Bullish Margin Narratives

Niu Technologies (NasdaqGM:NIU) closed out FY 2025 with fourth quarter revenue of C¥676.2 million and a basic EPS loss of C¥1.10, alongside trailing twelve month revenue of C¥4.3 billion and a basic EPS loss of C¥0.49. Over recent quarters the company has seen revenue range from C¥681.9 million to C¥1.7 billion, with quarterly basic EPS swinging between a loss of C¥0.49 and a profit of C¥1.02. This underscores how volatile earnings have been around a still unprofitable margin profile. See our...
NYSE:AXTA
NYSE:AXTAChemicals

Axalta Coating Systems (AXTA) Valuation After Earnings Miss And Weaker Revenue Guidance

Why Axalta Coating Systems (AXTA) Is Back Under Pressure Axalta Coating Systems (AXTA) has come under fresh scrutiny after underperforming in its latest quarter and guiding to a mid single digit revenue decline, alongside rising raw material costs and softer North American demand. See our latest analysis for Axalta Coating Systems. The Q4 2025 earnings miss and softer Q1 2026 outlook have been reflected in the share price, with a 30 day share price return showing an 18.17% decline and a 1...
NasdaqGS:SAFT
NasdaqGS:SAFTInsurance

Assessing Safety Insurance Group (SAFT) Valuation After Improved Combined Ratio And Dividend Strength

Safety Insurance Group (SAFT) is in focus after reporting an improved combined ratio of 99% in 2024, a well covered dividend, and a 4.2% yield on its investment portfolio. See our latest analysis for Safety Insurance Group. The share price sits at $73.53 after a 1 day share price return of 0.40% and a 7 day share price return of 1.21%. However, the 30 day share price return of 7.31% and year to date share price return of 2.88% point to fading short term momentum. The 3 year total shareholder...
NasdaqGS:GRAL
NasdaqGS:GRALBiotechs

Does GRAIL (GRAL) Elevating Josh Ofman to CEO Reframe Its Management Quality Narrative?

In March 2026, GRAIL, Inc. announced that CEO Bob Ragusa will retire on June 1, 2026, with President Josh Ofman, MD, MSHS, set to become CEO and join the Board, while Ragusa remains as a senior advisor through March 2027. This leadership transition places a long-time internal executive with deep clinical and health policy experience at the center of GRAIL’s next phase of development. Next, we’ll examine how Ofman’s planned move from president to CEO could reshape GRAIL’s investment narrative...
NYSE:TSQ
NYSE:TSQMedia

Townsquare Media (TSQ) Returns To Loss In Q4 EPS Challenging Profit Recovery Narrative

Townsquare Media (TSQ) FY 2025 Earnings Snapshot Townsquare Media (TSQ) has wrapped up FY 2025 with Q4 revenue of US$106.5 million and a basic EPS loss of US$0.32, while trailing twelve month figures show revenue at US$427.4 million and a basic EPS loss of US$0.71. Over recent quarters the company has seen revenue move from US$117.8 million in Q4 2024 to US$106.5 million in Q4 2025, with EPS shifting from a profit of US$1.59 to a loss of US$0.32. This sets up a story where revenue is...
NYSE:NVST
NYSE:NVSTMedical Equipment

A Look At Envista Holdings (NVST) Valuation After Recent Share Price Volatility

Why Envista Holdings is on investors’ radar today Envista Holdings (NVST) is back in focus after recent trading, with the share price closing at $25.02 and short term returns mixed between a 1 day gain and a weaker past week. Over the past month the stock has recorded a 14% decline, while the past 3 months show a 14% total return, giving investors a compact snapshot of recent volatility and recovery. See our latest analysis for Envista Holdings. That recent 14.25% 3 month share price return...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Cytokinetics MYQORZO Data Sheds Light On oHCM Outlook And Valuation

Cytokinetics (NasdaqGS:CYTK) presented new clinical data on MYQORZO (aficamten) for obstructive hypertrophic cardiomyopathy at a major cardiology conference. The updates covered exercise capacity outcomes, effectiveness across patients with and without hypertension, and safety during treatment interruption and restart. The new analyses expand the clinical profile of MYQORZO, a recently approved oHCM therapy, and add detail on how the drug performs in real treatment scenarios. Cytokinetics...
NYSE:SFBS
NYSE:SFBSBanks

Is ServisFirst Bancshares (SFBS) Offering A Chance After Recent Share Price Weakness

Wondering whether ServisFirst Bancshares is attractively priced at its current level? This article focuses squarely on what the recent share performance might be telling you about value. The stock last closed at US$73.73, with returns of 2.7% year to date, a 14.4% decline over the past month, and a 9.7% decline over the past year, while still showing a 35.2% gain over three years and 31.1% over five years. These mixed returns have kept ServisFirst Bancshares on the radar for investors who...
NYSE:GOLD
NYSE:GOLDRetail Distributors

Gold.com Board Shift Brings New Capital Markets Focus For Investors

Gold.com (NYSE:GOLD) has appointed Juan Sartori to its Board of Directors with immediate effect. The move coincides with the retirement of longtime director Beverley Lepine after more than a decade of service. Sartori brings experience in digital finance, commodities, and global capital markets to the company’s board. Gold.com, trading at $46.72, has seen a 34.4% return year to date and a 72.0% return over the past year, with longer term 3 year and 5 year returns of 74.1% and 183.2%...
NasdaqGS:FTDR
NasdaqGS:FTDRConsumer Services

Frontdoor (FTDR) Valuation Check After Strong Q4 Beat And Softer Full Year Guidance

Frontdoor (FTDR) is back in focus after reporting Q4 revenue of $433 million, a 13.1% year over year increase, along with earnings that exceeded expectations and full year revenue guidance slightly below projections. See our latest analysis for Frontdoor. Since the earnings release, Frontdoor’s share price has moved to US$64.22, with a 13.38% 1 month share price return and a 69.58% 1 year total shareholder return, which may suggest building momentum despite some recent short term pullback. If...
NYSE:LEU
NYSE:LEUOil and Gas

Centrus Energy (LEU) Is Up 8.7% After Oklo JV, AI Push Reframe Nuclear Fuel Role – What’s Changed

In March 2026, Oklo Inc. and Centrus Energy agreed to pursue a joint venture for high-assay low-enriched uranium deconversion at Centrus’ Piketon, Ohio site, while Centrus also reported lower-than-expected quarterly earnings affected by a delayed Russian shipment and outlined increased capital spending plans. Centrus’ recent collaboration with Palantir on AI-driven enrichment optimization and its talks with Oklo on an integrated HALEU hub highlight how technology and fuel-cycle partnerships...
NasdaqGS:UBSI
NasdaqGS:UBSIBanks

Is United Bankshares (UBSI) Still Sensibly Priced After The Recent Share Price Pullback?

Wondering if United Bankshares at around US$39.38 is still a fair deal or starting to look stretched? This article breaks down what the current share price might be implying about value. The stock’s returns range from a 1.4% decline over the last 7 days and a 10.7% decline over the last 30 days, to gains of 2.6% year to date, 17.5% over 1 year, 25.7% over 3 years and 25.2% over 5 years. These figures can mean very different things depending on how you think about risk and timing. Recent...